Jul 2026· npj Systems Biology and Applications· 0 citations
Medicine
TL;DR
These findings establish a mechanistic link between OSM signaling, HIF1A activation, and CCM, demonstrating how cytokine-driven transcriptional reprogramming coordinates epithelial cell migration.
Abstract
Extracellular signals strongly influence cell behavior, yet the mechanisms by which specific ligands mediate changes in phenotype remain unclear. The cytokine Oncostatin M (OSM) regulates homeostasis, wound healing, inflammation, and cancer progression. We previously found that OSM induces collective cell migration (CCM), a process whereby cells move as cohesive units while retaining cell-cell contacts, in MCF10A mammary epithelial cells. Here, we investigated how OSM drives CCM by comparing its effects with those elicited by epidermal growth factor (EGF) and interferon gamma (IFNG), defining ligand-specific phenotypes and molecular networks. Integrative transcriptomic and proteomic analyses identified hypoxia-inducible factor-1 (HIF1A) and signal transducer and activator of transcription 3 (STAT3) as central regulators of OSM responses. Functional validation revealed that HIF1A drives transcriptional programs associated with hypoxia, metabolic reprogramming, and immune pathways. Complement signaling emerged as a downstream effector of HIF1A, and its inhibition disrupted OSM-induced clustering and CCM. These findings establish a mechanistic link between OSM signaling, HIF1A activation, and CCM, demonstrating how cytokine-driven transcriptional reprogramming coordinates epithelial cell migration. Analysis of public breast cancer data indicate that this pathway is active in human tumors and may contribute to tissue remodeling, repair, and metastasis.
It is demonstrated that chemical hypoxia induces cell-type-specific transcriptional and post-transcriptional responses in breast and liver cancer cells, and miRNA-mediated regulation may contribute to differential tumor adaptation to hypoxic stress and highlight the importance of cellular context in hypoxia-associated...
Okan Sancer, Pınar Aslan Koşar, Uğur Şahin et al.· Drug and chemical toxicology...· 0 citations
It is demonstrated that IL-13Rα2 is a crucial, context-dependent signaling receptor that maintains the p-EMT state and malignant progression via the STAT6 axis, making it a precise therapeutic target for advanced, phenotypically plastic colorectal cancer.
Jian Lu, Marko Kornmann, B. Traub· Molecular and Cellular Bioch...· 1 citation
A comprehensive overview of the functional regulation of MDK in cancer is provided, summarizing its molecular signaling pathways, contributions to tumor microenvironment remodeling, and involvement in therapeutic resistance.
D. Wusiman, Xue-Zeng Yang, Xiao-Tong Yan et al.· Cancer Genetics· 0 citations
Insulin-like growth factor binding protein 2 (IGFBP2) has emerged as a multifarious and context-dependent oncoprotein that links several mechanisms in the tumor microenvironment (TME) including oncogenic signaling, extracellular matrix (ECM) remodeling, immune evasion, and therapy resistance. Beyond its established rol...
Provas Das, Shannon M. Conley, Prasanta Panja et al.· Biochimica et biophysica act...· 0 citations
The hallmarks of cancer is used as an organizing framework to synthesize preclinical, translational, and clinical evidence on chemokine circuits in glioblastoma and evaluated recurrent mechanistic pathways, distinguished causal functions from context-dependent biomarker associations, and assessed their therapeutic rele...
Rafal Chojak, Jillyn R. Turunen, Noah B. Drewes et al.· Journal of Neuro-Oncology· 0 citations
Using single-cell transcriptomics, lysyl oxidase (LOX) is identified as a driver of ccRCC progression, selectively enriched in a hypoxia/epithelial-mesenchymal transition (EMT) gene program associated with poor outcome.
B. Ulukan, O. Saatci, A. Madrigal et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.